SCHEMBL14985260

SCHEMBL14985260

CN(C)C(=O)c1ccc(Nc2nc(N[C@@H]3CCCCC3N)cnc2C(N)=O)cn1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LRRK2 Q5S007 3/20 0.66
▸ MAPK1 P28482 2/20 0.66
▸ CHEK2 O96017 2/20 0.66
▸ FER P16591 2/20 0.66
▸ CDC7 O00311 1/20 0.66
▸ PLK4 O00444 1/20 0.66
▸ CHEK1 O14757 1/20 0.66
▸ PDPK1 O15530 1/20 0.66
▸ DAPK3 O43293 1/20 0.66
▸ DYRK3 O43781 1/20 0.66
▸ JAK2 O60674 1/20 0.66
▸ ROCK2 O75116 1/20 0.66
▸ RPS6KA5 O75582 1/20 0.66
▸ PRKD3 O94806 1/20 0.66
▸ MAP4K4 O95819 1/20 0.66
▸ PAK4 O96013 1/20 0.66
▸ ABL1 P00519 1/20 0.66
▸ PRKCG P05129 1/20 0.66
▸ LCK P06239 1/20 0.66
▸ FYN P06241 1/20 0.66

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14956451 1.00 LRRK2 (0.66) LRRK2MAPK1CHEK2FERCDC7
SCHEMBL14955690 0.89 LCK (0.68) LRRK2MAPK1CHEK2FERCDC7
SCHEMBL16743234 0.86 SYK (0.62) SYKKCNH2AURKB
SCHEMBL14956161 0.85 LRRK2 (0.61) LRRK2MAPK1CHEK2FERCDC7
SCHEMBL14955619 0.85 LRRK2 (0.67) LRRK2MAPK1CHEK2FERCDC7
SCHEMBL14955613 0.84 MAPK1 (0.78) LRRK2MAPK1CHEK2FERCDC7
SCHEMBL14955324 0.84 LRRK2 (0.67) LRRK2MAPK1CHEK2FERCDC7
SCHEMBL14955556 0.84 LRRK2 (0.67) LRRK2MAPK1CHEK2FERCDC7
SCHEMBL14956831 0.84 JAK2 (0.67) LRRK2MAPK1CHEK2FERCDC7
SCHEMBL14955720 0.84 MAPK1 (0.67) LRRK2MAPK1CHEK2FERCDC7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013078466-A1 PYRAZINE KINASE INHIBITORS PORTOLA PHARMACEUTICALS, INC. (US) 2013-05-30 — — WO disclosed
Send feedback